▶ 調査レポート

臨床質量分析の世界市場レポート2020

• 英文タイトル:Global Clinical Mass Spectrometry Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。臨床質量分析の世界市場レポート2020 / Global Clinical Mass Spectrometry Sales Market Report 2020 / 20QY06-08700資料のイメージです。• レポートコード:20QY06-08700
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、臨床質量分析のグローバル市場について種類別(LC-MS、GC-MS、その他)、用途別(臨床診断、臨床研究)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・臨床質量分析市場の概要
・世界の主要地域別臨床質量分析市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の臨床質量分析市場規模2015-2026:種類別(LC-MS、GC-MS、その他)
・世界の臨床質量分析市場規模2015-2026:用途別(臨床診断、臨床研究)
・臨床質量分析の北米市場規模2015-2020
・臨床質量分析のヨーロッパ市場規模2015-2020
・臨床質量分析の中国市場規模2015-2020
・臨床質量分析の日本市場規模2015-2020
・臨床質量分析の東南アジア市場規模2015-2020
・臨床質量分析のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(AB Sciex (Danaher)、Bruker、Thermo Fisher、Agilent、Waters、Perkin Elmer、Shidmazu)
・臨床質量分析の製造コスト分析
・販売チャネル、流通業者、顧客
・臨床質量分析の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Clinical Mass Spectrometry Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Clinical Mass Spectrometry market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.

Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Clinical Mass Spectrometry market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Clinical Mass Spectrometry industry.
Based on our recent survey, we have several different scenarios about the Clinical Mass Spectrometry YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 885.5 million in 2019. The market size of Clinical Mass Spectrometry will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Clinical Mass Spectrometry market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Clinical Mass Spectrometry market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Clinical Mass Spectrometry market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Clinical Mass Spectrometry market. The report also includes nautical information, where it shows Clinical Mass Spectrometry market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Clinical Mass Spectrometry market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Clinical Mass Spectrometry market.
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).
Geographical Analysis:
Based on region, the global Clinical Mass Spectrometry market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Clinical Mass Spectrometry market are
AB Sciex (Danaher)
Bruker
Thermo Fisher
Agilent
Waters
Perkin Elmer
Shidmazu

Segment by Type
LC-MS
GC-MS
Others
Segment by Application
Clinical Diagnostics
Clinical Research
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Clinical Mass Spectrometry market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Clinical Mass Spectrometry market.
• The market share of the global Clinical Mass Spectrometry market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Clinical Mass Spectrometry market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Clinical Mass Spectrometry market.

レポート目次

1 Clinical Mass Spectrometry Market Overview
1.1 Clinical Mass Spectrometry Product Scope
1.2 Clinical Mass Spectrometry Segment by Type
1.2.1 Global Clinical Mass Spectrometry Sales by Type (2020-2026)
1.2.2 LC-MS
1.2.3 GC-MS
1.2.4 Others
1.3 Clinical Mass Spectrometry Segment by Application
1.3.1 Global Clinical Mass Spectrometry Sales Comparison by Application (2020-2026)
1.3.2 Clinical Diagnostics
1.3.3 Clinical Research
1.4 Clinical Mass Spectrometry Market Estimates and Forecasts (2015-2026)
1.4.1 Global Clinical Mass Spectrometry Sales Growth Rate (2015-2026)
1.4.2 Global Clinical Mass Spectrometry Revenue and Growth Rate (2015-2026)
1.4.3 Global Clinical Mass Spectrometry Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Clinical Mass Spectrometry Industry Impact
1.5.1 How the Covid-19 is Affecting the Clinical Mass Spectrometry Industry
1.5.1.1 Clinical Mass Spectrometry Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Clinical Mass Spectrometry Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Clinical Mass Spectrometry Players to Combat Covid-19 Impact

2 Clinical Mass Spectrometry Estimate and Forecast by Region
2.1 Global Clinical Mass Spectrometry Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Clinical Mass Spectrometry Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Clinical Mass Spectrometry Sales Market Share by Region (2015-2020)
2.2.2 Global Clinical Mass Spectrometry Revenue Market Share by Region (2015-2020)
2.3 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Clinical Mass Spectrometry Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Clinical Mass Spectrometry Estimates and Projections (2015-2026)
2.4.2 Europe Clinical Mass Spectrometry Estimates and Projections (2015-2026)
2.4.3 China Clinical Mass Spectrometry Estimates and Projections (2015-2026)
2.4.4 Japan Clinical Mass Spectrometry Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Clinical Mass Spectrometry Estimates and Projections (2015-2026)
2.4.6 India Clinical Mass Spectrometry Estimates and Projections (2015-2026)
3 Global Clinical Mass Spectrometry Competition Landscape by Players
3.1 Global Top Clinical Mass Spectrometry Players by Sales (2015-2020)
3.2 Global Top Clinical Mass Spectrometry Players by Revenue (2015-2020)
3.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Mass Spectrometry as of 2019)
3.4 Global Clinical Mass Spectrometry Average Price by Company (2015-2020)
3.5 Manufacturers Clinical Mass Spectrometry Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Clinical Mass Spectrometry Players (Opinion Leaders)
4 Global Clinical Mass Spectrometry Market Size by Type
4.1 Global Clinical Mass Spectrometry Historic Market Review by Type (2015-2020)
4.1.1 Global Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
4.1.2 Global Clinical Mass Spectrometry Revenue Market Share by Type (2015-2020)
4.1.3 Global Clinical Mass Spectrometry Price by Type (2014-2020)
4.2 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Clinical Mass Spectrometry Sales Forecast by Type (2021-2026)
4.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2021-2026)
4.2.3 Global Clinical Mass Spectrometry Price Forecast by Type (2021-2026)
5 Global Clinical Mass Spectrometry Market Size by Application
5.1 Global Clinical Mass Spectrometry Historic Market Review by Application (2015-2020)
5.1.1 Global Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
5.1.2 Global Clinical Mass Spectrometry Revenue Market Share by Application (2015-2020)
5.1.3 Global Clinical Mass Spectrometry Price by Application (2015-2020)
5.2 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Clinical Mass Spectrometry Sales Forecast by Application (2021-2026)
5.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Application (2021-2026)
5.2.3 Global Clinical Mass Spectrometry Price Forecast by Application (2021-2026)

3 North America Clinical Mass Spectrometry Market Facts & Figures
3.2 North America Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
3.3 North America Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
3.4 North America Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

4 Europe Clinical Mass Spectrometry Market Facts & Figures
4.2 Europe Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
4.3 Europe Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
4.4 Europe Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

5 China Clinical Mass Spectrometry Market Facts & Figures
5.2 China Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
5.3 China Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
5.4 China Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

6 Japan Clinical Mass Spectrometry Market Facts & Figures
6.2 Japan Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
6.3 Japan Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
6.4 Japan Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

7 Southeast Asia Clinical Mass Spectrometry Market Facts & Figures
7.2 Southeast Asia Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

8 India Clinical Mass Spectrometry Market Facts & Figures
8.2 India Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
8.3 India Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
8.4 India Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Clinical Mass Spectrometry Business
12.1 AB Sciex (Danaher)
12.1.1 AB Sciex (Danaher) Clinical Mass Spectrometry Corporation Information
12.1.2 AB Sciex (Danaher) Clinical Mass Spectrometry Business Overview and Total Revenue
12.1.3 AB Sciex (Danaher) Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AB Sciex (Danaher) Clinical Mass Spectrometry Products Offered
12.1.5 AB Sciex (Danaher) Recent Development
12.2 Bruker
12.2.1 Bruker Clinical Mass Spectrometry Corporation Information
12.2.2 Bruker Clinical Mass Spectrometry Business Overview and Total Revenue
12.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bruker Clinical Mass Spectrometry Products Offered
12.2.5 Bruker Recent Development
12.3 Thermo Fisher
12.3.1 Thermo Fisher Clinical Mass Spectrometry Corporation Information
12.3.2 Thermo Fisher Clinical Mass Spectrometry Business Overview and Total Revenue
12.3.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Thermo Fisher Clinical Mass Spectrometry Products Offered
12.3.5 Thermo Fisher Recent Development
12.4 Agilent
12.4.1 Agilent Clinical Mass Spectrometry Corporation Information
12.4.2 Agilent Clinical Mass Spectrometry Business Overview and Total Revenue
12.4.3 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Agilent Clinical Mass Spectrometry Products Offered
12.4.5 Agilent Recent Development
12.5 Waters
12.5.1 Waters Clinical Mass Spectrometry Corporation Information
12.5.2 Waters Clinical Mass Spectrometry Business Overview and Total Revenue
12.5.3 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Waters Clinical Mass Spectrometry Products Offered
12.5.5 Waters Recent Development
12.6 Perkin Elmer
12.6.1 Perkin Elmer Clinical Mass Spectrometry Corporation Information
12.6.2 Perkin Elmer Clinical Mass Spectrometry Business Overview and Total Revenue
12.6.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Perkin Elmer Clinical Mass Spectrometry Products Offered
12.6.5 Perkin Elmer Recent Development
12.7 Shidmazu
12.7.1 Shidmazu Clinical Mass Spectrometry Corporation Information
12.7.2 Shidmazu Clinical Mass Spectrometry Business Overview and Total Revenue
12.7.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Shidmazu Clinical Mass Spectrometry Products Offered
12.7.5 Shidmazu Recent Development

13 Clinical Mass Spectrometry Manufacturing Cost Analysis
13.1 Clinical Mass Spectrometry Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Clinical Mass Spectrometry
13.4 Clinical Mass Spectrometry Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Clinical Mass Spectrometry Distributors List
14.3 Clinical Mass Spectrometry Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Clinical Mass Spectrometry Sales (Units) Growth Rate by Type (2020-2026)
Table 2. Global Clinical Mass Spectrometry Sales (Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Clinical Mass Spectrometry Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Clinical Mass Spectrometry Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Clinical Mass Spectrometry Players to Combat Covid-19 Impact
Table 8. Global Market Clinical Mass Spectrometry Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Clinical Mass Spectrometry Sales (Units) by Region (2015-2020)
Table 10. Global Clinical Mass Spectrometry Sales Market Share by Region (2015-2020)
Table 11. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Clinical Mass Spectrometry Revenue Share by Region (2015-2020)
Table 13. Global Clinical Mass Spectrometry Sales (Units) Forecast by Region (2021-2026)
Table 14. Global Clinical Mass Spectrometry Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Clinical Mass Spectrometry Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Clinical Mass Spectrometry Revenue Share Forecast by Region (2021-2026)
Table 17. Global Clinical Mass Spectrometry (Units) of Key Companies (2015-2020)
Table 18. Global Clinical Mass Spectrometry Sales Share by Company (2015-2020)
Table 19. Global Clinical Mass Spectrometry Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Clinical Mass Spectrometry Revenue Share by Company (2015-2020)
Table 21. Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Mass Spectrometry as of 2019)
Table 22. Global Clinical Mass Spectrometry Average Price (K USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Clinical Mass Spectrometry Manufacturing Sites and Area Served
Table 24. Manufacturers Clinical Mass Spectrometry Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Clinical Mass Spectrometry Players
Table 27. Global Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 28. Global Clinical Mass Spectrometry Sales Share by Type (2015-2020)
Table 29. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Clinical Mass Spectrometry Price (Units) by Type (2015-2020)
Table 31. Global Clinical Mass Spectrometry Sales Share by Type (2021-2026)
Table 32. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Clinical Mass Spectrometry Revenue Share by Type (2021-2026)
Table 34. Global Clinical Mass Spectrometry Price (Units) by Type (2021-2026)
Table 35. Global Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 36. Global Clinical Mass Spectrometry Sales Share by Application (2015-2020)
Table 37. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Clinical Mass Spectrometry Price (Units) by Application (2015-2020)
Table 39. Global Clinical Mass Spectrometry Sales (Units) by Application (2021-2026)
Table 40. Global Clinical Mass Spectrometry Sales Share by Application (2021-2026)
Table 41. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Clinical Mass Spectrometry Revenue Share by Application (2021-2026)
Table 43. Global Clinical Mass Spectrometry Price (Units) by Application (2021-2026)
Table 44. United States Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 45. United States Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 46. United States Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 47. United States Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 48. United States Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 49. United States Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
Table 50. Europe Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 51. Europe Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 52. Europe Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 53. Europe Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 54. Europe Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 55. Europe Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 56. China Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 57. China Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 58. China Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 59. China Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 60. China Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 61. China Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
Table 62. Japan Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 63. Japan Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 64. Japan Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 65. Japan Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 66. Japan Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 67. Japan Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 69. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 71. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 73. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
Table 74. India Clinical Mass Spectrometry Sales (Units) by Company (2015-2020)
Table 75. India Clinical Mass Spectrometry Sales Market Share by Company (2015-2020)
Table 76. India Clinical Mass Spectrometry Sales (Units) by Type (2015-2020)
Table 77. India Clinical Mass Spectrometry Sales Market Share by Type (2015-2020)
Table 78. India Clinical Mass Spectrometry Sales (Units) by Application (2015-2020)
Table 79. India Clinical Mass Spectrometry Sales Market Share by Application (2015-2020)
Table 80. AB Sciex (Danaher) Corporation Information
Table 81. AB Sciex (Danaher) Description and Business Overview
Table 82. AB Sciex (Danaher) Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 83. AB Sciex (Danaher) Clinical Mass Spectrometry Product
Table 84. AB Sciex (Danaher) Recent Development
Table 85. Bruker Corporation Information
Table 86. Bruker Description and Business Overview
Table 87. Bruker Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 88. Bruker Clinical Mass Spectrometry Product
Table 89. Bruker Recent Development
Table 90. Thermo Fisher Corporation Information
Table 91. Thermo Fisher Description and Business Overview
Table 92. Thermo Fisher Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 93. Thermo Fisher Clinical Mass Spectrometry Product
Table 94. Thermo Fisher Recent Development
Table 95. Agilent Corporation Information
Table 96. Agilent Description and Business Overview
Table 97. Agilent Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 98. Agilent Clinical Mass Spectrometry Product
Table 99. Agilent Recent Development
Table 100. Waters Corporation Information
Table 101. Waters Description and Business Overview
Table 102. Waters Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 103. Waters Clinical Mass Spectrometry Product
Table 104. Waters Recent Development
Table 105. Perkin Elmer Corporation Information
Table 106. Perkin Elmer Description and Business Overview
Table 107. Perkin Elmer Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 108. Perkin Elmer Clinical Mass Spectrometry Product
Table 109. Perkin Elmer Recent Development
Table . Shidmazu Corporation Information
Table . Shidmazu Description and Business Overview
Table . Shidmazu Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2015-2020)
Table . Shidmazu Clinical Mass Spectrometry Product
Table . Shidmazu Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Clinical Mass Spectrometry Distributors List
Table 118. Clinical Mass Spectrometry Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Mass Spectrometry Product Picture
Figure 2. Global Clinical Mass Spectrometry Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Clinical Mass Spectrometry Market Share by Application in 2020 & 2026
Figure 6. Clinical Diagnostics Examples
Figure 7. Clinical Research Examples
Figure 8. Global Clinical Mass Spectrometry Sales (Units) Growth Rate (2015-2026)
Figure 9. Global Clinical Mass Spectrometry Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Clinical Mass Spectrometry Price Trends Growth Rate (2015-2026) (K USD/Unit)
Figure 11. Global Clinical Mass Spectrometry Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Clinical Mass Spectrometry Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Clinical Mass Spectrometry Sales (Units) Growth Rate (2015-2026)
Figure 15. Europe Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Clinical Mass Spectrometry Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Clinical Mass Spectrometry Players Market Share by Revenue in Clinical Mass Spectrometry 2015 & 2019
Figure 26. Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Clinical Mass Spectrometry Revenue Share by Type (2015-2020)
Figure 28. Global Clinical Mass Spectrometry Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Clinical Mass Spectrometry Revenue Share by Application (2015-2020)
Figure 30. Global Clinical Mass Spectrometry Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 32. United States Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 33. Europe Clinical Mass Spectrometry Sales Market Share by Company in 2019
Figure 34. Europe Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 35. Europe Clinical Mass Spectrometry Sales Market Share by Application in 2019
Figure 36. China Clinical Mass Spectrometry Sales Market Share by Company in 2019
Figure 37. China Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 38. China Clinical Mass Spectrometry Sales Market Share by Application in 2019
Figure 39. Japan Clinical Mass Spectrometry Sales Market Share by Company in 2019
Figure 40. Japan Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 41. Japan Clinical Mass Spectrometry Sales Market Share by Application in 2019
Figure 42. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Company in 2019
Figure 43. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 44. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application in 2019
Figure 45. India Clinical Mass Spectrometry Sales Market Share by Company in 2019
Figure 46. India Clinical Mass Spectrometry Sales Market Share by Type in 2019
Figure 47. India Clinical Mass Spectrometry Sales Market Share by Application in 2019
Figure 48. AB Sciex (Danaher) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bruker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Agilent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Waters Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Perkin Elmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Shidmazu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Clinical Mass Spectrometry
Figure 57. Manufacturing Process Analysis of Clinical Mass Spectrometry
Figure 58. Clinical Mass Spectrometry Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed